Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.

While the makers of Ozempic have stated that its GLP-1 medication was not made to be used as a weight loss drug, nor should ...

AbbVie has joined the ranks of pharma groups trying to develop weight-loss drugs, licensing a long-acting amylin analogue from Denmark's Gubra in a deal valued at more than $2.2 billion.

Title: Efficacy of a novel oral amylin analog and the development of an oral GLP-1/amylin co-formulated tablet to produce high in vivo plasma exposures Date/Time: June 21, 2025, 12:30–1:30 p.m ...

In 2024, the Oxford University Press declared “brain rot” the word of the year. If Ohio is just a midwestern state to you and mewwing is something your cat does, you might not be as familiar ...

Going to the beach is good for your brain, according to science. Visiting the coast can help you relieve stress and get more active—and it may even change the way you cope with pain.

A recent preclinical study showed that amycretin activates GLP-1, amylin, and calcitonin receptors in human, mouse, and rat cell-based systems, and targets areas of the mouse brain that regulate food ...

Amylin agonists have been associated with transient increases in mean aldosterone concentrations, indicating activation of the renin–angiotensin–aldosterone system. 18 In the present study, we also ...